Importance of training-induced effects on the arterial vascular system and the skeletal musculature in the therapy regime of congestive heart failure NYHA II/III;Stellenwert von trainingsbedingten rückwirkungen am arteriellen gefäßsystem und der skelettmuskulatur in der therapie der herzinsuffizienz nyha II/III

Zeitschrift fur Kardiologie

Volumn 90, Issue 11, 2001, Pages 813-823

  Huonker, M ^a   Keul, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Congestive heart failure; Endurance training; Exercise therapy; Extracardial training effects

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; SPIRONOLACTONE;

ARTERY DIAMETER; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; FITNESS; HEART HYPERTROPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART OUTPUT; HEMODYNAMICS; HUMAN; MUSCLE ATROPHY; MUSCLE EXERCISE; PHYSICAL ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SHEAR STRESS;

CARDIAC OUTPUT; ENDOTHELIUM, VASCULAR; EXERCISE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035193090     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170080     Document Type: Review

References (101)

1. Report of the american college of cardiology/american heart association task force on practice guidelines (committee on evaluation and management of heart failure)
2. Capillary supply of the quadriceps femoris muscle of man: Adaptive response to exercise
3. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries
4. The therapeutic role of exercise in patients with orthotopic heart transplant
5. Consideration of conduit and resistance vessels in regulation of blood flow
6. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: Effects on functional capacity, quality of life, and clinical outcome
7. Cardiovascular adaptations to physical training
8. Zur dynamik des rückstroms aus der vena femoralis
9. Recent insight into therapy of congestive heart failure: Focus on ACE inhibition and angiotensin-II antagonism
10. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2
11. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function
12. The sympathetic nervous system in heart failure
13. Left ventricular diastolic function in elite athletes with physiologic cardiac hypertrophy
14. Ventilation in chronic heart failure: Effects of physical training
15. Mechanical stress mechanisms and the cell. An endothelial paradigm
16. Differential effects of training on the control of skeletal muscle perfusion
17. Physical training, vegetative regulation, and cardiac hypertrophy
18. Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting
19. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure
20. Skeletal muscle failure in heart failure
21. Changes in the peripheral circulation in heart failure
22. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart
23. Alterations of skeletal muscle in chronic heart failure
24. Vascular remodeling: Mechanisms and implications
25. Effect of training on circulatory response to exercise
26. Cardiac output in athletes
27. Angiogenic factors
28. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure
29. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure
30. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation
31. Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure
32. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure
33. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial
34. Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles
35. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
36. Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: An echocardiographic study
37. Differences in EDNO contribution to arteriolar diameters at rest and during functional dilation in striated muscle
38. Endurance training in humans: Aerobic capacity and structure of skeletal muscle
39. Physical training improves endothelial function in patients with chronic heart failure
40. What makes blood vessels grow?
41. Form, size and function of the sports heart - Differentiation from pathological findings
42. Structural and functional adaptations of the cardiovascular system by training
43. Exercise hemodynamics and oxygen delivery measurements using rebreathing techniques in heart transplant patients
44. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure
45. Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure
46. Pathophysiology and treatment of congestive heart failure
47. Adaptive regulation of wall shear stress to flow change in the canine carotid artery
48. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
49. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation
50. The athlete's heart-haemodynamics and structure
51. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation
52. Adaptive changes in work capacity, skeletal muscle capillarization and enzyme levels during training and detraining
53. A controlled trial of exercise rehabilitation after heart transplantation
54. The benefit of graded physical exercise in chronic heart failure
55. Effects of diurnal variability and exercise training on properties of large arteries
56. Endothelium-dependent vasodilation is attenuated in patients with heart failure
57. Exercise training-induced coronary vascular adaptation
58. Debate: Vascular remodelling
59. Sympathische regulation des herz-kreislaufsystems bei körperlicher belastung
60. Can patients with chronic congestive heart failure benefit from physical conditioning? A review of the potential adaptations to training
61. Evidence of reduced respiratory muscle endurance in patients with heart failure
62. Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure
63. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
64. Diastolic heart failure
65. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure
66. Contribution of Endothelium-Derived Nitric Oxide (EDNO) to the skeletal muscle blood flow response to exercise
67. Therapeutic advances in heart failure
68. Influence of post-surgery time after cardiac transplantation on exercise responses
69. Predictors of response to exercise training in severe chronic congestive heart failure
70. Improvement of aerobic capacity in chronic congestive heart failure. Which training method is appropriate?
71. The cytokine response to physical activity and training
72. Neurohormonal interactions and adaptations in congestive heart failure
73. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
74. Coronary arteries in physiological hypertrophy: Echocardiographic evidence of increased proximal size in elite athletes
75. Diagnostic and prognostic indicators in chronic heart failure
76. Crucial role of endothelium in the vasodilator response to increased flow in vivo
77. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle
78. Functional mechanism of the heart in chronic physiologic overload (athletic heart)
79. Flow-induced release of endothelium-derived relaxing factor
80. Endothelium as a transducing surface
81. Hemodynamic adaptations to exercise
82. The nature of the training response; peripheral and central adaptations of one-legged exercise
83. Role of endothelium in the control of arterial diameter by blood flow
84. The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy
85. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure
86. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure
87. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure
88. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects
89. Endothelium-derived hyperpolarizing factor: A new endogenous inhibitor from the vascular endothelium
90. Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones
91. Early occurrence of respiratory muscle deoxygenation assessed by near-infrared spectroscopy during leg exercise in patients with chronic heart failure
92. Modulation of vascular endothelial gene expression by physical training in patients with chronic heart failure
93. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy
94. Role of NO in flow-induced remodeling of the rabbit common carotid artery
95. Defining diastolic heart failure: A call for standardized diagnostic criteria
96. Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining
97. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance
98. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure
99. The renin-angiotensin system and experimental heart failure
100. Tumor necrosis factor down regulates an endothelial nitric oxide synthase mRNA by shortening its half-life